Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2014-03-12 Declaration of Voting R…
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details changes in the stake of major shareholders (The Capital Group Companies, Inc. and Capital Research and Management Company) in Fresenius SE & Co. KGaA, referencing German Securities Trading Act (WpHG) notification requirements regarding voting rights crossing thresholds (specifically crossing below 3%). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements'.
2014-03-12 English
Report Publication Announcement 2014
Report Publication Announcement Classification · 100% confidence The document is a short announcement dated March 10, 2014, titled 'Fresenius SE & Co. KGaA: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG' and specifically states 'Fresenius SE & Co. KGaA hereby announces that the following financial reports shall be disclosed:'. It then lists future disclosure dates for the 'Annual financial report', 'Annual financial report of the group', and 'Quarterly financial report of the group within the 1st half-year (Q1)'. Because the document's primary function is to announce *when* other reports will be published, and it is very short (1986 chars), it fits the definition of a Report Publication Announcement (RPA) according to Rule 2 ('MENU VS MEAL' rule). It is not the report itself (like 10-K or IR).
2014-03-10 English
Credit Suisse Global Healthcare Conference
Investor Presentation Classification · 98% confidence The document is titled as a presentation given at the 'Credit Suisse – Global Health Care Conference, March 5, 2014'. It contains financial highlights, segment results, outlooks, and guidance for the year 2014, based on 2013 performance. This format—a presentation deck used to communicate strategy and results to investors at a specific event—is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or IR, nor is it a brief announcement of a report (RPA). The content is detailed enough to be an IP, rather than a brief Fund Factsheet (FS).
2014-03-05 English
Goldman Sachs Leveraged Finance Healthcare Conference
Investor Presentation Classification · 99% confidence The document is titled with a conference name ("Goldman Sachs - Leveraged Finance Healthcare Conference") and a date (March 4, 2014). The content consists of an agenda, company overview slides, detailed segment performance data (Fresenius Medical Care, Fresenius Kabi, Fresenius Helios), financial highlights, and strategic outlook points, all presented in a slide deck format typical of an investor presentation. This structure strongly indicates that the document is an Investor Presentation (IP) delivered at a conference, rather than a formal regulatory filing (like 10-K or IR) or a brief announcement (like ER or RPA).
2014-03-04 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly states the total number of voting rights as of February 28, 2014. This type of announcement, which reports on the total number of shares carrying voting rights, is a specific regulatory disclosure. While it is a regulatory announcement, it does not fit the definitions for AGM-R, DVA (which is for *results* of a vote), or any of the primary financial reports (10-K, IR, ER). It is a specific type of corporate action/share structure update. Given the options, it is closest to a general regulatory filing (RNS) or potentially a specific capital/share structure update. However, since it is a direct announcement of a specific regulatory metric (Total Voting Rights) required under German law (WpHG), and it is not a change in share count (SHA) or a transaction in own shares (POS), the most appropriate general regulatory category is RNS, as it is a mandatory disclosure that doesn't fit the other specific categories like DIV or DVA. The document length is very short (1325 chars), suggesting it is a brief notification, supporting the RNS classification over a comprehensive report.
2014-02-28 English
Fresenius SE & Co. KGaA: Fiscal year 2013: Group net income at top end of guidance, exceeding EUR1 billion - Positive Group outlook for 2014
Earnings Release Classification · 100% confidence The document is titled 'Fiscal year 2013: Group net income at top end of guidance, exceeding EUR1 billion – Positive Group outlook for 2014' and contains key financial highlights for the full fiscal year 2013 (sales, EBIT, net income, EPS) along with guidance for 2014. It is explicitly labeled as an 'Ad hoc announcement' disseminated via DGAP, which typically precedes or summarizes a more comprehensive report. Since it provides the initial, high-level summary of the period's financial performance rather than the full, detailed report (like a 10-K or IR), it fits the definition of an Earnings Release (ER). The document length is short (3725 chars), and it focuses on results and outlook, confirming it is an announcement of results, not the full report itself. FY 2013
2014-02-25 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.